Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,222Revenue $M2,587Net Margin (%)0.4Z-Score0.8
Enterprise Value $M8,175EPS $-0.1Operating Margin %3.3F-Score6
P/E(ttm))0Cash Flow Per Share $11.8Pre-tax Margin (%)-4.9Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %0Current Ratio2.5Lower Leverage y-yY
Price/Cash Flow1.6y-y EBITDA Growth Rate %-20.1ROA % (ttm)0.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M84.5ROI % (ttm)-6.6Gross Margin Increase y-yN

Gurus Latest Trades with ALR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALRJoel Greenblatt 2014-12-31 Buy 0.12%$36.31 - $40.2
($38.6)
$ 49.9723%New holding382,075
ALRMario Gabelli 2014-12-31 Reduce-0.01%$36.31 - $40.2
($38.57)
$ 49.9723%Reduce -23.00%203,100
ALRJoel Greenblatt 2014-09-30 Sold Out -0.01%$34.26 - $41.14
($37.35)
$ 49.9725%Sold Out0
ALRJohn Keeley 2014-06-30 Buy 0.9%$32.86 - $37.68
($35.57)
$ 49.9729%New holding1,335,700
ALRMario Gabelli 2014-06-30 Add0.03%$32.86 - $37.68
($35.57)
$ 49.9729%Add 206.84%242,845
ALRJoel Greenblatt 2014-06-30 Buy 0.01%$32.86 - $37.68
($35.57)
$ 49.9729%New holding11,057
ALRMario Gabelli 2014-03-31 Add0.01%$33.99 - $39.34
($36.55)
$ 49.9727%Add 646.65%79,145
ALRPrivate Capital 2013-09-30 Reduce-1.54%$24.38 - $34.49
($30.53)
$ 49.9739%Reduce -41.64%927,844
ALRPrivate Capital 2012-06-30 Add0.71%$17.98 - $25.97
($20.85)
$ 49.9758%Add 35.93%1,734,463
ALRSeth Klarman 2012-06-30 Sold Out -0.12%$17.98 - $25.97
($20.85)
$ 49.9758%Sold Out0
ALRMario Gabelli 2012-06-30 Reduce$17.98 - $25.97
($20.85)
$ 49.9758%Reduce -25.93%10,000
ALRSeth Klarman 2012-03-31 Reduce-1.3%$22.21 - $26.64
($22.87)
$ 49.9754%Reduce -93.12%137,700
ALRSeth Klarman 2011-12-31 Reduce-0.72%$18.51 - $26.43
($23.09)
$ 49.9754%Reduce -35.48%2,000,000
ALRDavid Dreman 2011-12-31 Sold Out -0.53%$18.51 - $26.43
($23.09)
$ 49.9754%Sold Out0
ALRMario Gabelli 2011-12-31 Reduce$18.51 - $26.43
($23.09)
$ 49.9754%Reduce -27.03%13,500
ALRPrivate Capital 2011-09-30 Add0.27%$20.62 - $38.43
($27.49)
$ 49.9745%Add 13.49%1,353,656
ALRPrivate Capital 2011-06-30 Add0.14%$33.98 - $41
($38.19)
$ 49.9724%Add 5.74%1,192,781
ALRGeorge Soros 2011-06-30 Sold Out $33.98 - $41
($38.19)
$ 49.9724%Sold Out0
ALRMario Gabelli 2011-03-31 Reduce-0.03%$36.17 - $40.32
($38.34)
$ 49.9723%Reduce -77.58%18,500
ALRGeorge Soros 2011-03-31 Reduce$36.17 - $40.32
($38.34)
$ 49.9723%Reduce -29.29%14,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Guerdan MelissaSVP, Global Quality & Reg. 2015-04-06Sell2,500$50-0.06view
Guerdan MelissaSVP, Global Quality & Reg. 2015-03-23Sell13,476$48.353.35view
BRIDGEN JOHNSr VP, Business Develop 2015-03-17Sell25,000$48.532.97view
Flakne CarlaVP, Chief Accounting Officer 2015-03-16Sell8,500$48.992view
Flakne CarlaVP, Chief Accounting Officer 2015-03-16Sell8,500$48.992view
Gladwell MarkSenior VP, Global Operations 2015-02-23Sell13,292$44.6211.99view
Flakne CarlaVP, Chief Accounting Officer 2015-01-16Sell10,000$42.4517.71view
BRIDGEN JOHNSr VP, Business Develop 2014-12-11Sell50,000$37.0734.8view
Teitel DaveCFO 2014-08-15Sell10,000$35.0742.49view
Torchilin KateVP, Connected Health 2013-12-11Sell8,547$33.7348.15view

Press Releases about ALR :

    Quarterly/Annual Reports about ALR:

    News about ALR:

    Articles On GuruFocus.com
    Diamond Hill Capital Comments on Alere Inc Mar 17 2015 
    Corsair Capital's Analysis of Alere Mar 06 2015 
    DENTSPLY´s Growth Opportunities Dec 16 2014 
    Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
    Mario Gabelli Comments on Alere Inc Nov 21 2014 
    Mario Gabelli’s Asset Fund Q3 2014 Commentary Nov 21 2014 
    Cohen Has Busy Third Quarter Nov 19 2014 
    Alder Reports Encouraging Copper and Gold Metallurgical Recovery Results for the Stockpiles and Tail Nov 05 2014 
    Diamond Hill Capital Comments on Alere Inc Oct 17 2014 
    Diamond Hill Select Fund Third Quarter 2014 Commentary Oct 17 2014 


    More From Other Websites
    Altera Announces First Quarter Results Apr 23 2015
    Convening the Annual General Meeting of Alior Bank S.A. Apr 23 2015
    Agreement on the Merger Plan of Alior Bank S.A. and Meritum Bank ICB S.A. Apr 22 2015
    The first announcement of the intended merger of Alior Bank S.A. and Meritum Bank ICB S.A. Apr 22 2015
    James Pallotta’s Raptor Capital Hits Homerun with Hospira, Inc. (HSP) Apr 17 2015
    Altera Announces First Quarter Earnings Conference Call Apr 16 2015
    Closing of the placement of the series H shares – supplement to current report no. 17/2015 of 4... Apr 16 2015
    Notification of transactions on the Bank’s shares Apr 13 2015
    Altera Joins Industrial Internet Consortium to Influence Global Ecosystem for Internet of Things Apr 13 2015
    Altera to Demonstrate Ultra HD End-to-End Solutions at NAB 2015 Apr 09 2015
    Altera and TSMC Innovate Industry-first, UBM-free WLCSP Packaging Technology Platform for MAX® 10... Apr 07 2015
    Alere Inc. Reports Employment Inducement Awards Pursuant to NYSE Rule 303A.08 Apr 06 2015
    Alere Inc. Reports Employment Inducement Awards Pursuant to NYSE Rule 303A.08 Apr 06 2015
    Alere Wins FDA Nod for Strep A Test, Applies for CLIA Waiver - Analyst Blog Apr 06 2015
    Information about a change in the share in the total number of votes Apr 02 2015
    Alere Receives FDA Clearance for Alere™ i Strep A Rapid Molecular Test Apr 02 2015
    Alere Receives FDA Clearance for Alere™ i Strep A Rapid Molecular Test Apr 02 2015
    Current report prepared as per the provisions of art. 225 of Law no. 297/2004 Apr 02 2015
    Notification of transactions on the Bank’s shares Apr 01 2015
    Alior Bank results for 2014 Apr 01 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK